Oblique Therapeutics
Fighting metastatic cancer
- CEO: Owe Orwar
- First investment year: 2015
- Fund: West Sweden
- Business sector: Life Science

Oblique Therapeutics is an early stage innovation-driven pharmaceutical company aiming at developing transformative medicines against advanced and metastatic cancer.